




Involving patients and nurses in choosing between two validated questionnaires to
identify Chemotherapy Induced peripheral Neuropathy before implementing in clinical
practice – a qualitative study.
Jensen, Marlene Æ.; Yilmaz, Mette N.; Pedersen, Birgith
Published in:
Journal of Clinical Nursing





Accepted author manuscript, peer reviewed version
Link to publication from Aalborg University
Citation for published version (APA):
Jensen, M. Æ., Yilmaz, M. N., & Pedersen, B. (2020). Involving patients and nurses in choosing between two
validated questionnaires to identify Chemotherapy Induced peripheral Neuropathy before implementing in
clinical practice – a qualitative study. Journal of Clinical Nursing, 29(19-20), 3847-3859.
https://doi.org/10.1111/jocn.15417
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
This article has been accepted for publication and undergone full peer review but has not been 
through the copyediting, typesetting, pagination and proofreading process, which may lead to 
differences between this version and the Version of Record. Please cite this article as doi: 
10.1111/JOCN.15417
 This article is protected by copyright. All rights reserved
Title page 
Involving patients and nurses in choosing between two validated questionnaires to identify 
Chemotherapy Induced peripheral Neuropathy before implementing in clinical practice – a 
qualitative study.
Short running title: To identify side effects from cancer treatment
Authors:
Marlene Æ. Jensen, RN, MCN1,  Mette N. Yilmaz, MD1, 2, Birgith Pedersen, RN, PhD 1, 2, 4,  
Author affiliations
1Department of Oncology, Aalborg University Hospital, Denmark, 2Clinical Cancer Research 
Center, Aalborg University Hospital, Denmark, 3Clinic for Surgery and Oncology, Aalborg 




Clinic for Surgery and Oncology, Aalborg University Hospital, 




We would like to thank the participants for their valuable contribution, providing knowledge of 











This article is protected by copyright. All rights reserved
The authors declare that no potential conflicts of interests exist with regard to the research, 
authorship and publication of this article.
Funding
The project receive funding from the Novo Nordic Fund
Authors’ contributions
MÆJ, MY and BP designed the original study. MÆJ and BP gathered and analyzed the data. They 
drafted the paper that was further refined in discussions with MY. All researchers revised and 











This article is protected by copyright. All rights reserved 
 
PROF. BIRGITH  PEDERSEN (Orcid ID : 0000-0002-7688-4362) 
 
 
Article type      : Original Article 
 
 
Aims and objectives  
To explore from a nurse and patient perspective what questionnaire - “Functional assessment 
of cancer treatment gynecological group neurotoxicity” or “Oxaliplatin-Associated 
Neuropathy Questionnaire” - best describes chemotherapy-induced peripheral neuropathy and 
its influence on everyday life in a comprehensive and meaningful way, prior to 
implementation in daily practice. 
 
Background 
Patients experience chemotherapy-induced peripheral neuropathy during and after 
chemotherapy for colorectal cancer with Oxaliplatin. This neuropathy is difficult to describe 
for patients and to identify for nurses. To address the specific needs of patients and improve 
identification of neuropathy and its influence on everyday life, we wanted to implement a 
questionnaire in clinical practice. 
 
Design 
A phenomenological hermeneutic frame of reference was used. 
 
Method 
Semi-structured interviews with 15 patients and two focus groups with eight cancer nurses 
were used for data collection. Data was organized and interpreted by content analytical steps 
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The analysis resulted in two main-themes 1) ‘To dig deeper’ with sub-themes ‘to identify the 
line between acceptable and non-acceptable chemotherapy-induced peripheral neuropathy’, 
and ‘searching for a precise description’. 2). ‘When everything is interrelated’ with 




Involving patients and nurses in choosing between the two questionnaires revealed that 
neither alone was sufficient to describe the patients’ experiences. Instead, it seems essential 
to implement both questionnaires, using the answers as a basis for a dialogue to address the 
patients’ specific needs.  
 
Relevance for clinical practice 
Using patients and nurses perspectives in a complementary way may provide a solid 
foundation before starting an implementation process in clinical practice. However, attention 
must be paid to potential barriers and facilitators as well as the fact that a successful 
implementing process requires leadership and information sharing.  
 
Keywords 
Chemotherapy, neuropathy, colorectal neoplasm, questionnaires, implementing, nurses, 






This paper explores from a nurse and patient perspective which of two validated 
questionnaires best describes Chemotherapy Induced Peripheral Neurotoxicity (CIPN) in a 
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implementing one of them in daily practice. Understanding and valuing patients’ experience-
based knowledge and applying their expertise in research processes may positively influence 
the outcome e.g. the patients’ engagement and willingness in responding questionnaires 
(Duffett, 2017). In addition, involving patients in deciding a questionnaire may contribute to 
increasing quality and high compliance in follow-ups (Althubaiti, 2016; Schwappach, 2010). 
Moreover, involving clinical nurses in decision-making may contribute to tailoring a 
subsequent intervention to the clinical setting and take into account potential barriers and 
facilitators (Stacey et al., 2015). In this specific case, the questionnaire is meant to support 
patients in describing their experiences of CIPN and assist health care professionals (HCPs) 
to assess CIPN during and after chemotherapy for colorectal cancer (CRC) in a specific 
clinical setting.  Thus, to take into account the priority of patients, the reality of clinical 
settings and facilitate the subsequent implementation of the questionnaire, patients and cancer 
nurses were involved in the study process. 
 
Background  
CIPN is one of the most common side effects to platinum-based chemotherapy like 
Oxaliplatin (Banach et al., 2016). CIPN is described as nerve damage that may develop 
during and after chemotherapy triggered by drug accumulation (Seretny et al., 2014). CIPN 
affects both the sensory and motor nerve system and includes dysesthesias, tingling and 
burning sensations and pain involving both lower and upper extremities and the head and 
neck area (Banach et al., 2016).  
As early detection of it is a means to prevent persistent CIPN (Massey et al., 2014), it is 
important to encourage patients to report CIPN as soon as possible and monitor it closely 
(Banach et al., 2016). However, patients find it difficult to express how they experience CIPN 
as the symptoms are multifaceted and to some degree blurry (Miltenburg & Boogerd, 2014; 
Tanay et al., 2017). Accordingly, it is important to apply tools to identify CIPN that are 
acceptable and meaningful for the patients, which may be clarified through patient 
involvement.  
According to Staley and Barron (Staley & Barron, 2019), patient involvement must be 
tailored for a purpose and be regarded as a conversation that supports learning for the 
involved parties (Staley & Barron, 2019). To learn from patients’ perspectives before 
implementing a questionnaire in clinical practice, patients may participate as consultants, 










This article is protected by copyright. All rights reserved 
literature highlights patients’ increasing involvement in research and quality processes e.g. 
transforming guidelines into lay language (Boelens et al., 2014) and investigating 
acceptability and feasibility for a screening tool (Ristevski et al., 2015). However, no studies 
were found about involvement of patients with gastro- intestinal cancer in choosing a 
questionnaire for CIPN identification.   
In addition to patients, nurses play an essential role in meeting patients’ concerns and needs 
when patients visit the outpatient clinic for chemotherapy. They follow up on information 
about the risk of developing CIPN and contribute to identifying early signs of it (Miltenburg 
& Boogerd, 2014). This requires that nurses have insight into and knowledge of the extent of 
CIPN and are able to take relevant actions that may prevent and/or alleviate CIPN. Likewise, 
they are responsible for the initial assessment of CIPN and for reporting to the physician if 
they evaluate CIPN to be serious and intervention to be required. Involving both patients and 
nurses to explore the meaningfulness and comprehensiveness of the questionnaires is 
therefore anticipated to facilitate the implementation process.  
Choice of instrument 
CIPN has been found to obstruct normal activities like driving, writing, picking up things, 
carrying out hobbies, household, duties and exercising (Bennett et al., 2012; Tofthagen, 
2010). Besides, the experience of CIPN depends on its intensity, analgesic efficacy, self-care 
strategies, the level of pain increase, sleep disturbance, fatigue, and interference with valued 
activities (Bakitas, 2007). Multiple instruments have been developed to identify CIPN but no 
gold standard has been established, although it is common for physicians to use the scales of 
National Cancer Institute - Common Terminology Criteria Adverse Events (NCI-CTCAE) in 
their assessments of patients’ adverse events. However, comparing a clinician-based grading 
system like the CTCAE scale with patient-reported outcome measures shows that 
professionals score patients’ conditions lower than patient’ themselves and thus identify 
fewer patients with CIPN (Molassiotis et al., 2019; Nyrop et al., 2019).  
In addition to the NCI-CTCAE scale, the European Organization for Research and Treatment 
of Cancer developed a questionnaire CIPN20 (EORTC-CIPN20). This measures sensory, 
motor and autonomic and functioning in patients experiencing CIPN (Tofthagen et al., 2011). 
Although CIPN20 contains questions about side effects in upper and lower extremities and 
from the head area, it does not assess the grade of distress symptoms cause. Thus, according 
to Kieffer et al. (2017), CIPN20 is useful for a simple additive checklist.  
Based on a review on CIPN tools, Haryani et al. (2017) recommend ‘Functional assessment 











This article is protected by copyright. All rights reserved 
questionnaire combines questions about quality of life and neurotoxic side effects. Patients 
are asked to answer questions about physical wellbeing (seven items), social wellbeing 
(seven items), emotional wellbeing (six items), functional wellbeing (seven items) and 11 
items regarding neurotoxicity on a scale from 0 to 4. Although FACT/GOG-Ntx was 
developed for use among patients with gynecological cancer and other neurotoxic 
chemotherapy it is widely used in studies on CIPN among patients with different cancer 
diagnoses including CRC (Dault et al., 2016; Driessen et al., 2012; Mols et al., 2014; 
Vatandoust et al., 2014).  
Moreover, there has been increased attention on widening the assessment of CIPN to include 
an examination of physical symptoms from the mouth and face and investigate to what extent 
the symptoms affect daily activities (Driessen et al., 2012; Gustafsson et al., 2016; Leonard et 
al., 2005). In 2005, Leonard et al. developed a questionnaire for assessing CIPN divided into 
three areas: the upper and lower extremities and orofacial areas with ten, nine and ten items 
respectively. First, the patient is asked to grade CIPN on a scale from one (almost nothing) to 
five (a lot) and next to grade how CIPN affects everyday life (Leonard et al., 2005). The 
questionnaire was later called OANQ, an abbreviation for Oxaliplatin-Associated Neuropathy 
Questionnaire (Gustafsson et al., 2016).  
Based on this review of instruments to detect CIPN, FACT/GOG-Ntx contains questions 
about quality of life and OANQ about how CIPN affects daily activities. Thus, it seemed that 
one of these would be the most useful to implement. In addition, both questionnaires were 
translated into Danish and have undergone reliability testing in detecting CIPN (Calhoun et 
al., 2003; Driessen et al., 2012; Gustafsson et al., 2016).  
 
Aim 
The aim of this study was to explore, by involving patients and nurses perspectives, which of 
the two validated questionnaires - FACT/GOG-Ntx and OANQ - best describes CIPN and its 
influence on everyday life in a comprehensive and meaningful way before implementing one 
of them in daily practice. 
 
Method 
This qualitative explorative study was conducted in a phenomenological hermeneutic frame 
of reference, which is a mode of understanding in qualitative interviewing that aims to reveal 
interviewed subjects’ perspective (Brinkmann & Kvale, 2015). To explore the patients’ 
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this kind of interviewing may provide detailed information in the respondents’ own words 
and allow for supplementary questions (Brinkmann & Kvale, 2015).   
To explore the nurses’ perspective on the use of the questionnaires, Focus Groups (FGs) were 
used for data collection as discussions and interactions between participants in FGs may 
provide a platform for sharing and comparing experiences and opinions among participants 
(Groenkjaer et al., 2011; Halkier, 2003; Kitzinger, 1994; Krueger & Casey, 2009).  The 
Consolidated Criteria for reporting Qualitative Research Checklist was used as a guideline for 
facilitating and securing a complete reporting of the study (Tong et al., 2007). 
 
Participants 
At the oncological outpatient clinic, at a Danish University Hospital, fifteen patients; eight 
males and seven females, mean age 62.7 years (range 53 – 72) were included consecutively 
when they attended the outpatient clinic for their chemotherapy (Table 1). Danish speaking 
patients receiving adjuvant or palliative treatment with the chemotherapeutic drug Oxaliplatin 
for gastro intestinal cancer were included independent of their treatment cycle. Patients with 
cognitive impairments, difficulties in speaking and understanding Danish were excluded. The 
first author, a development nurse (Master of Clinical Nursing) from the outpatient clinic unit 
who occasionally participated in patient care, approached the patients and gave them 
information about the project before their final consent. None of the patients declined to 
participate. 
To familiarize the patients with the questionnaires, they completed them three times during 
their treatment cycles (Table 1). Completion on three occasions was anticipated to provide 
information of potentially different experiences across time in the individual interviews.  
To ensure that included participants are knowable informants and able to share their 
experiences about the topic under investigation, the nurses were included purposefully among 
nurses that had dealt with patients filling in the questionnaires. Eight out of 14 potential 
nurses working two specific days from the CRC team were included. Thus, the risk for 
selection bias was decreased. The nurses were also approached by the first author, the 
development nurse from the outpatient clinic. They were all females, mean age 41.1 years 
(range 37 – 49) and with oncological experience mean 6.5 years (range 1 – 11) (Table 2). 
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Ethics 
In Denmark, the Danish Research Ethics Committee does not assess and register qualitative 
studies. However, the project observes all regulations concerning research ethics according to 
The Nordic Nurses Federation (Nordic Nurses, 2003) and the Helsinki Declaration (The 
World Medical Association, 2018) and is notified to the Danish Data protection Agency 
(journal number: ID 2018 150). The participants were informed about the project orally and 
in writing and signed informed consent. Participation was voluntary and the participants were 
informed about their right to withdraw from the study at any time without consequences. 
Anonymity and confidentiality are ensured by coding data and exchanging names with ID 




By means of an interview guide (Table 3), the first author who has skills in interviewing 
patients from her master program and daily practice conducted the individual semi-structured 
interview. The interview lasted from 6 to 21 minutes (equivalent to 2.6 hours of total 
interviewing). 
The FGs with four and three nurses respectively took place at the end of a working day. The 
last author (MSc in Nursing, PhD) who is skilled in interviewing and moderating for a 
scientific purpose, conducted the FG. In the discussion, the moderator posed the opening 
question, ‘What questionnaire do you find most useful to describe the patients’ experiences of 
CIPN and their influence on everyday life’. The participants answered the opening question 
one by one, thus creating a platform for further discussion. Afterwards they challenged each 
other about their current practice, advantages, and disadvantages regarding implementing a 
questionnaire. Questions from the moderator were only asked to clarify and elaborate on what 
was said during the discussion or to ensure consistency between the interviews and the FGs, 
asking the participants to discuss the same question posed to the patients but moderately 
transformed (Table 4). At the end of the discussion, a debriefing took place to ensure that 
everybody had had the opportunity to contribute from her experiences (Brinkmann & Kvale, 
2015; Morgan, 1997; Redmond & Curtis, 2009). The FGs lasted 49 and 55 minutes.  
The individual semi-structured interviews and FGs took place at the outpatient clinic in a 
room convenient for the purpose. All interviews were conducted in Danish, digitally 
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English with caution by the authors not to change the intended meaning. Data saturation 
was obtained in the individual interviews as well as in the FGs as conducting the second FG 
and the last three individual interviews provided no meaningful new insight regarding 
choosing between the two questionnaires. Thus, due to the data saturation, the interviews 
and FGs provided rich data to fulfil the aim of the study and supported the credibility of the 
study (Graneheim & Lundman, 2004).  
Analysis 
To get a sense of the whole, the authors read the texts several times. Subsequently, the 
analysis was accomplished in an interplay between the researchers (first and last author) and 
data in an iterative process of reading, analyzing and rereading (Brinkmann & Kvale, 2015). 
According to Brinkman and Kvale (2015), the analysis from a phenomenological 
hermeneutic approach aims to describe the manifest meaning from the transcribed text and 
next interpreting the latent meaning, that goes beyond what is said to a deeper understanding 
(Brinkmann & Kvale, 2015). Inspired by content analytical steps, essential meaning units 
from individual interviews and FGs were identified and further condensed into manifest and 
latent content and coded (Graneheim & Lundman, 2004) (Table 5). Thus, the analysis moved 
from ‘what was in the data’ to ‘what the data was about’, thinking interpretively (Morse, 
2008). After coding, we combined and arranged the data from individual interviews and FGs 
in themes and sub-themes (Graneheim & Lundman, 2004) (Table 5). In the whole process the 
researchers’ pre-understanding was taken into consideration by questioning each other’s 
interpretations until consensus was reached. 
 
Results 
The analysis provided two main themes, each elaborated in two sub-themes. Both patients 
and nurses found it important to implement a questionnaire that helped them to ‘To dig 
deeper’ and thus improving their ability to ‘identify the line between acceptable and non-
acceptable CIPN’ as well as ‘searching for a precise description’. However, it was a 
challenge to choose between the two questionnaires ‘When everything is interrelated’ and it 
was important to be ‘aware of different perspectives and understandings’ while ‘recognizing 
potential pitfalls’. 
 
‘To dig deeper’ 
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As the main issue for the nurses was to prevent persistent CIPN, it was important to clarify 
the demands for whether the development of CIPN prompted a change in the chemotherapy. 
As a nurse said: ‘Our responsibility is not to prescribe. We need a tool to proceed with’ (N7). 
Acknowledging their specific role as mediators between patients and physicians, the nurses 
explored CIPN in their own way but found it difficult to identify systematically. The nurses 
anticipated that a specific tool could support their responsibility to dissociate between 
acceptable and non-acceptable CIPN and provide data for the physician for dose maintenance 
or reduction of the chemotherapy’ 
‘I think the questionnaires will help us to explore the side effects in-depth, to 
ask questions exhaustively and reveal details, which I do not do in my current 
practice so systematically’ (N3). 
Thus, applying a questionnaire could reveal problems that normally were not articulated in 
the relationship with the patient and dig deeper into the experience of CIPN. Furthermore, it 
could assist the nurses to obtain comprehensive details from the patient and in this way ‘get a 
shovel deeper’ (N2). Not only the nurses found implementing questionnaires important, the 
patients also did so. 
‘Using the questionnaire makes me think differently and more than before. I 
admit that. The questionnaire forced me to be aware of what happens in my 
body. How did I manage, what did I experience – before the questionnaire I did 
not reflect on it’ (P6). 
 
Answering the questionnaire could push to a deeper reflection and provide additional words 
for the patients’ experiences. From this perspective filling in a questionnaire could be a 
benefit and contribute to exploring CIPN more deeply and to identifying the line between 
acceptable and non-acceptable CIPN. Thus, both the patients and nurses were motivated in 
using questionnaires to explore CIPN. 
Searching for a precise description 
In general, the patients considered the questionnaires were easy to fill in although some 
preferred FACT-GOG/Ntx and others OANQ. However, testing the questionnaires revealed 
that some patients were able to answer them independently of guidance, whereas others 
needed additional help to understand the grading and structure of the questionnaires.  
‘It is important that you read the questions properly. Some I read more than 
once. What did the question mean? You also have to be aware of the division of 
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the nurses helped us to pay attention to this’ (P2). 
‘I did not know how to describe my prickly sensation in hands and arms. I chose 
three – it was very unpleasant when it appeared but it disappeared quickly. 
Whether it was almost nothing or a lot, I could not tell’ (P9).  
The quotes illustrate the request for a heightened awareness of patients’ ability to understand 
and reply to the questionnaires and point to the importance of information and guidance from 
the nurses before filling in the questionnaire for the first time. Without information and 
guidance about filling in the questionnaires, the answering could lose trustworthiness and 
leave the patient alone with misunderstandings.  
‘I saw he graded five, but he had just said he had no side effects. Then I read 
the question again ‘oh no, that was wrong’ he said. It is a matter of 
understanding, that grade one is no side effects and five is a lot’ (N1). 
Although the nurses were interested in knowing ‘how the side effects are right now’ (N1), as 
a point of reference for the next chemotherapy, they also attached significance to whether 
CIPN increased in intensity and persisted between the chemotherapy sessions.   
  ‘I find it difficult….the patient can experience pain in the jaw….but for how? 
Answering ‘almost none or quite a lot’ tells nothing about how long it has 
lasted, which we also need to know’ (N5).  
Neither of the questionnaires depicted how long CIPN persisted in between the chemotherapy 
sessions, which was a part of the investigation and assessment of CIPN.  In the FACT-
GOG/ntx, the patients were asked to recall their side effects during the last week, whereas 
OANQ did not suggest a specific time point. Thus, searching for precise description would 
require continuous attention to the development of CIPN in between the scheduled 
chemotherapy sessions to compensate for this missing information. Consequently, a potential 
disadvantage for implementing the questionnaire was the risk of losing the real description of 
CIPN, which could be minimized if the answers from the questionnaires were used as a 
starting point for a dialogue. 
 
When everything is interrelated 
Awareness of different perspectives and understandings  
In the nurses’ current practice, their starting point in the conversation with the patients was 
what was prevailing for them. Implementing a questionnaire, they were aware that the 
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comprehensive exploration of physical sensations and functionality or a one-sided focus on 
questions from the questionnaire.  
‘Normally, the conversation starts naturally on what the patient feels is urgent 
right now – contrary to using a questionnaire that covers everything (about 
neuropathy). It is a matter of exploring what is urgent for the patients as well as 
all neuropathic side effects’ (N1). 
Being attentive to the interrelatedness of symptoms and everyday life, the nurses strove not to 
overlook worries that were important for the patient and their everyday living. Exploring the 
influence of CIPN on everyday life felt more natural using FACT-GOG/Ntx. Likewise, filling 
in this questionnaire could support the patients’ vocabulary to describe their own experiences. 
A patient said, ‘I could have used the questionnaire (when I started the treatment) to put into 
words how I feel. What is normal, how much is it okay to be affected’ (P3).  
Implementing a questionnaire may affect the patients psychologically because filling in the 
questionnaires forced the patient to recognize side effects they did not understand, 
overlooked or repressed. This could be a positive effect as, I found out …. Okay my 
discomfort may originate from the chemo. It is the reason for my condition (P14). Another 
patient said the questionnaires covered almost everything and that FACT-GOG/Ntx hit the 
emotions in an uncomfortable way, ‘These questions (….) are coming close to you when you 
are sitting here alone (….). In addition, you suddenly consider ‘can I get these side effects as 
well (P2)’. Thus, being confronted with questions from the questionnaires seems to require 
attention to how patients during and after chemotherapy cope and enter into learning 
processes.  
Caring for patients’ potential defense mechanisms, acknowledging the risk for talking past 
each other and not recognizing their perspectives, the nurses currently ‘encourage the 
patients to use their own words’ (N4). In their efforts to reach a shared language, they 
furthermore tried to increase and complement the patient’s vocabulary with other patients’ 
descriptions of CIPN and use their experience from former situations to explore the present 
patient’s experience.  
‘You can describe it with words from another patient, ‘Is it like walking on 
cotton wool? No, it is not like that. Is it like walking on needles? Yes, it seems 
like this’.  
(….). Asking questions and explaining symptoms in different ways to reach 
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These statements reveal how the nurses currently pay attention to the patient that may 
understand information and report CIPN differently. To reach the patient’s perspective and 
provide the best data for decision on the dose of chemotherapy the questionnaires can 
contribute to a more complete reporting style. However, it seems still important to take into 
consideration the difference between patients’ and professionals’ perspectives, pre-
understandings and language. 
 
Recognizing potential pitfalls 
Initially the nurses assessed OANQ as appropriate for the exploration of CIPN but they were 
aware of potential pitfalls if they just focused on the items in this questionnaire. 
Acknowledging that exploring the grade of CIPN was their primary aim, the ’soft’ 
information and helping the patients with everyday concerns came next. Nevertheless, they 
paid attention to the interrelatedness between physical sensations and impairment and their 
influence on physical, emotional, socially, and functional wellbeing in everyday life, which 
was explored to a higher degree using FACT- GOG/Ntx 
 ‘Initially, information and action regarding neuropathic side effects come first 
everyday life comes after. Although OANQ focuses on CIPN, we should talk 
about quality of life as well. Overwhelming fatigue may prevent one from 
leaving the house (….). What does it mean to them? Regarding FACT-
GOG/Ntx; if you struggle hard with side effects without having any network, it 
can be difficult. On the other hand, if our goal is to identify patients suffering 
from CIPN, OANQ is more relevant’ (N1).  
In the FGs, the nurses moved between which questionnaire was deemed most suitable 
regarding its focus mainly on CIPN and whether the data obtained from the questionnaires 
also should depict how patients were influenced in their everyday living in a broad sense. The 
initial assessment of OANQ illustrated that this questionnaire could indirectly reveal the 
effect on everyday living but limited to functioning and symptoms from the hands, arms, feet, 
legs and face areas. Thus, implementing this questionnaire alone would lead to missing 
information about everyday concerns. Although OANQ also was deemed suitable regarding 
the attention to the development of CIPN by patients and nurses, they articulated this inter-
relatedness. 
‘OANQ is best if you focus on facts, but you cannot use it if you need to know 
something about my social life. If I lived alone without nearby friends and 
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‘I think FACT-GOG/Ntx is good because it asks questions about nausea and 
energy, which you may also suffer from. On the other hand, OANQ asks 
questions about all odd thing appearing in your hands. They are good, both of 
them’ (P3). 
It became clear how the two questionnaires complemented each other and how the 
application of both could contribute to a nursing perspective that incorporates the patient’s 
physical state and functioning as well as quality of life. Thus, implementing both 
questionnaires could support the nurses in the clinical practice, where they stress the 
importance of talking about what could be important for the patient and at the same time 
getting valid information on the patient’s CIPN to prevent it from becoming consistent.  
 
Discussion 
This study aimed to explore which of two validated questionnaires best describes CIPN and 
its influence on everyday life in a comprehensive and meaningful way before implementing 
one in daily practice. As there is no gold standard regarding which questionnaire is most 
comprehensive in identifying CIPN, it was reasonable to involve patients and nurses in the 
decision. To take into account potential barriers and facilitators that may enhance 
implementing the questionnaire for daily use prospectively (Stacey et al., 2015), patients’ and 
nurses’ priorities and opinions would be essential to integrate in the implementing process.  
 
Although involving patients in research is often met with skepticism about their ability to 
contribute to the process, this opinion is changing and the interest in patient-reported 
outcomes is increasing (Duffett, 2017). In addition to choosing the questionnaire, engaging 
patients and clinical nurses sought to tailor the subsequent intervention. However, it may be 
discussed on which level the patients were involved. De Wit et al. (2019) define patient 
involvement according to the role the patient takes in the researching process. In accordance 
with Duffet’s (2017) description of the consulting role, de Wit el al. (2019) discuss patient 
involvement where patients contribute with their individual experience and the information 
flows from patient to the researcher often by means of a kind of interviewing (de Wit et al., 
2019). Thus, the consulting role was evident in our study. They also took an implicitly 
advising role when they displayed their opinion about the questionnaires. Even though the 
patients were experts in their disease and experiences of CIPN, they were not involved as 
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study (de Wit et al., 2019). Anticipated to take an essential role in the subsequent 
implementation process, the nurses were involved as well as consultants and advisors. 
 
In agreement with Harvey and Kitson (2016), successful implementation relies on the 
recipients, those who are affected by and influence implementation at the individual as well 
as at the collective team level. Involving the recipients makes it possible to take into account 
their motivation, values and beliefs, skills and knowledge, etc. (Harvey & Kitson, 2016). The 
recipients in our study were patients and nurses. All of them put a positive value on 
implementing a questionnaire that helps them to ‘To dig deeper’, to identify the line between 
acceptable and non-acceptable CIPN and ensure a precise description. According to Weiner 
(Weiner, 2009) it may indicate that both patients and nurses were ready to adopt the changes 
and willing to participate in the implementing process in a positive way. However, our 
findings showed that we needed to consider the nurses’ current practice, patients’ potential 
difficulties in understanding the questionnaire, as well as emotions appearing among the 
patients. Failing to consider these potential pitfalls in the implementing process may obstruct 
a successful implementation (Harvey & Kitson, 2016). 
According to Stacey, it is of great value to address potential barriers when changing 
professional practice and find a way to resolve them before starting the process (Stacey et al., 
2015). In our study, some barriers seemed to be associated with the risk of missing 
exploration of the patients’ experiences, which required awareness of different perspectives 
and understandings among the patients. Although the patients filled in both questionnaires 
three times, they still displayed difficulties due to trouble in understanding the questions and 
the grading, which did not correspond with their everyday language. A discrepancy between 
patients’ and HCPs’ languages and understanding is pointed out by Clark (Clark, 2008). Not 
taking care of these pitfalls and barriers may subsequently prevent a precise description and 
provide insufficient data for assessment of the dose of chemotherapy. To gain insight into the 
patients’ concerns and reach a shared understanding, Clark talks about different horizons that 
need to fuse. In this process, the patient and HCP increase their common understanding of a 
certain topic (Clark, 2008) in this case, identification of CIPN and its influence on everyday 
life. 
 
In addition to using a questionnaire, the nurses in our study stressed the need to maintain their 
current practice and talk about the patients’ primary concerns first and not to overlook what 
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not ensure the patients’ understanding of filling in the questionnaire. On the other hand, we 
found that implementing a questionnaire could support the patients in revealing urgent care 
needs associated with CIPN in a time-limited unit in a more systematic way. This is in 
accordance with Mooney et al. (2017) who demonstrated that using a questionnaire may 
contribute to intensifying symptom care and improve quality of life among the patients 
(Mooney, Berry, Whisenant, & Sjoberg, 2017). However, the outcome may rely on the ability 
to narrow or close the gap between the patients’ and the professionals’ estimation and grading 
of symptoms, a gap which in other studies is articulated as a crucial problem (Molassiotis et 
al., 2019; Mooney et al., 2017; Nyrop et al., 2019). Thus, closing the gap and dealing with 
different perspectives and understandings when everything is interrelated, the nurses need 
finely tuned communication to help the patients’ to express their fundamental care needs 
(Bundgaard, 2019). As CIPN may affect sleep disturbance (Hong, Tian, & Wu, 2014), 
normal daily activities (Bennett et al., 2012; Tofthagen, 2010) and lead to depression 
(Miltenburg & Boogerd, 2014) etc., the dialogue about physical and psycho-social side 
effects that potentially may lie outside the scope of the questionnaire may be essential to get 
an understanding of the patients’ preferences. Consequently, using their communicative 
skills, the nurses may support a fusion of horizons as stressed by Clark (Clark, 2008) and 
thereby accommodate the patients’ needs and deliver nursing care at a high quality, as shown 
in the study of Bundgaard et al. (2019). In addition, combining questionnaires with the 
dialogue about what is of concern for the patients may prevent the inherent risk when using a 
standardized communication form of producing care which is dehumanized and 
unaccompanied (Jørgensen, Kastrup Jensen, & Brogaard, 2019). 
Bearing this in mind, it appeared difficult for patients and nurses to choose one of the 
questionnaires ‘because everything is interrelated’. Although they agreed that OANQ 
(Gustafsson et al., 2016) seemed meaningful and comprehensive for assessing CIPN, this 
questionnaire lacked the opportunity to explore the patients’ quality of life with CIPN, which 
could increase the nurses’ understanding of the patients’ fundamental care needs. Focusing 
on grading CIPN alone could also imply a one-sided bio-medical perspective, which is not in 
accordance with nursing care that emphasizes the integration of the patients’ bio-
psychosocial needs (Feo, Kitson, & Conroy, 2018). On the other hand, choosing FACT-
GOG/Ntx (Haryani et al., 2017) alone was not sufficient to explore CIPN in depth. Thus, 
implementing both questionnaires from the perspective of patients and nurses would 
contribute to making the right decisions and ensuring a focus on what values most to the 
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Strengths and limitations 
Analyzing the data with content analytical steps, illustrating the structure for the analysis and 
presenting the findings related to quotes, makes it possible to follow our reasoning through 
the study (Erlingsson & Brysiewicz, 2017). Staying close to the data, continuous discussions 
in the research group and thorough revisions of the material limited the risk for confirmation 
bias in the research group (Althubaiti, 2016). Additionally, this makes it easier for the reader 
to assess the rigor of the study and supports the trustworthiness of the study (Erlingsson & 
Brysiewicz, 2017). Including patients consecutively may lead to slight variation in the 
sample. However, the patients displayed a variation in age, sex, diagnosis and treatment 
schedule, which enabled nuanced information (table 1) although some of the interviews were 
very short. This may have depended on whether the patient had experienced no or low-grade 
CIPN or had experienced increasing side effects. The latter case may have forced them to 
reflect deeper on how to fill in the questionnaire, which contributed to more data.  
To decrease selection bias, nurses who had dealt with patients filling in the questionnaires on 
two specific working days were purposefully included in FGs. Although Morgan (Morgan, 
1997) recommends three to six groups with six to ten participants when conducting FGs 
alone, he stresses that fewer participants also can be productive. However, the two FGs with 
fewer participants, revealed that the nurses were able to challenge each other’s opinions and 
discuss the benefits and disadvantages of the two questionnaires. Thus, combining the 
perspectives of 15 patients and 7 nurses on the same topic contributed with rich material, 
which supports the credibility of the study (Graneheim & Lundman, 2004). The 
transferability of the findings to other context depends on the reader (Graneheim & Lundman, 
2004). However, involving patients and nurses to participate in a study before selecting an 
instrument, seems appropriate and transferable to every setting where new questionnaires are 
intended to be implemented.  Combining the two specific questionnaires supports the 
opportunity to explore CIPN as well as its influence on everyday life in a comprehensive and 
meaningful way. However this seems only transferable to settings where patients are 
challenged with CIPN due to treatment with oxaliplatin.  
 
Conclusion 
The study provided insight into the importance of involving the patients and nurses in 
choosing between two validated questionnaires. This involvement made it possible to obtain 
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the intervention to the clinical setting and taking into account potential barriers and 
facilitators before planning the implementation process. Individual interviews with patients 
and FGs with nurses pointed to the need to choose both questionnaires to ensure the 
identification of CIPN and the influence on patients’ quality of life. In addition, the study 
revealed the requirement to focus on the patients’ preferences in an attempt to maintain 
essential values in nursing when improving the assessment of CIPN.  
 
Relevance to clinical practice 
The results can build upon existing literature on how involving users of the healthcare system 
and HCPs can be essential for the outcome of an implementing process. Involving patients in 
research processes may be a benefit of the study (Duffett, 2017). Patients have expertise 
based on their experiences while the HCPs have expertise in the specific disease, diagnosis 
and relevant actions. Using these perspectives in a complementary way may provide a solid 
foundation before starting an implementation process in clinical practice.  
Although the nurses in the study displayed readiness for the changes, attention must be paid 
to potential barriers and facilitators as well as the fact that a successful implementing process 
requires leadership and information sharing (Weiner, 2009). Firstly, an information sheet will 
be developed about how the nurses are expected to introduce and help the patients in filling in 
the questionnaire the first time either on paper or with electronic devices. This aims to take 
care of the risk of information bias, which may be a common one when patients are self-
reporting (Althubaiti, 2016). Additionally, by doing this the nurses will be able to identify 
patients that are unable to fill in the questionnaire electronically and provide the patient with 
another solution to describe their side effects. Secondly, and in accordance with fundamental 
values in nursing, attention must be paid to using the answers as a starting point for a 
dialogue that also explores the patients’ essential concerns and take care of their potential 
defense mechanisms. Thirdly, to recognize the nurses’ need to identify how long CIPN 
lasted, this additional question is added to the OANQ questionnaire, which was deemed best 




















How does this paper contribute to the wider global clinical community? 
 To take care of patient’s needs in accordance with essential values in nursing, the findings 
raise awareness of the importance of involving users of an instrument before 
implementing it in daily practice 
 To provide the HCPs valid information for further assessments, the patients need 
guidance before filling in the questionnaires the first time. 
 Combining first person perspectives from patients and nurses promotes an awareness of 
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Table 1. Participants - individual interviews 
ID Age Sex Type of 
cancer 
Treatment Chemotherapy Questionnaires filled in 
treatment cycle no. 
1 72 Female Rectum Palliative Folfox and 
bevacizumab 
3, 4 and 5 
2 59 Male Rectum Palliative Folfox and 
bevacizumab 
3, 4 and 5 
3 61 Female   Colon  Adjuvant  Folfox 2, 3 and 4 
4 73 Female  Pancreas  Palliative Folfox  7, 8 and 9 
5 55 Female   Colon  Palliative Folfox -iri 2, 3 and 4 
6 60 Male  Rectum  Adjuvant Folfox  6, 7 and 8 
7 53 Male  Colon  Adjuvant Folfox  4, 5 and 6 
8 57 Male  Rectum  Palliative Folfox and 
bevacizumab 
7, 8 and 9 
9 70 Male  Colon  Adjuvant Folfox  5, 6 and 7 
10 53 Female Colon  Adjuvant Folfox  2, 3 and 4 
11 60 Male Rectum Adjuvant Folfox  5, 6 and 7 
12 72 Female  Colon  Adjuvant Folfox  2, 3 and 4 
13 65 Male  Rectum  Adjuvant Folfox  3, 4 and 5 
14 59 Male  Colon  Adjuvant Folfox  2, 3 and 4 
15 69 Male  Colon  Palliative Panitumumab 
and folfox 
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Table 2. Participants FGs 
Participant 
ID 
Age  Sex Graduated (year) Oncological  
experience  
FG 1     
1 38  Female  2007 1  
2 34 Female 2008 10 
3 49 Female 1997 6  
4 37 Female 2006 4 
FG 2     
5 45 Female 1998 10 
6 45 Female 2001 3 











Table 3. Semi-structured questionnaire - the patient’s perspective  
 
How was your overall impression of filling in the questionnaires? 
How did the questionnaires support your possibility of describing your symptoms?  
Did the construct/set up of the questionnaires support or inhibit your opportunity to describe your 
symptoms?  
Did you need help from the nurse to fill in the questionnaires? 
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Table 4. Focus Group questions – the nurses perspective 
The opening question: 
‘What questionnaire do you find most useful to describe the patients’ experiences of CIPN 
and their influence on everyday life’. 
 
Potential probing questions: 
How was your overall impression of patients’ ability in filling in the questionnaires?  
How did the questionnaires support the patients’ possibility of describing their symptoms?  
Did the construct/set up of the questionnaires support or inhibit the patients’ ability to 
describe their symptoms and concerns?  
Did the patients need you help when filling in the questionnaires? 
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Table 5. Example structure analysis    
Quotes from the text – meaning unit 
 
Condensed manifest 
content close to the text 
(what is in the data) 
Condensed interpretation of 
the latent content (what the 
data is about) 
 
Code  Subtheme  Theme  
Our responsibility is not to prescribe. We need a 
tool to proceed with (N7).  
The nurses’ responsibility 
is to assess side effects. 
A tool is needed to assess 
side effects as a basis for the 
physician’s prescription. 




To dig deeper   
I think the questionnaire will help us to explore 
the side effects in-depth, to ask questions 
exhaustively and reveal details, which I do not do 
in my current practice so systematically (N3). 
Using a questionnaire can 
help nurses to explore side 
effects in depth. 
Applying a questionnaire 
can challenge the nurses’ 
current practice and support 
them in working more 
systematically. 
Benefit of a tool  
 




To dig deeper 
Using the questionnaire makes me think 
differently and more than before. I admit that. 
The questionnaire forces me to be aware of what 
happens in my body. How did I manage, what 
did I experience – before the questionnaire I did 
not reflect on it (P6).   
Answering the 
questionnaire force the 
patient to reflect on bodily 
sensations. 
Answering the questionnaire 
force the patient to realize 
bodily changes and think 
about her body in a different 
way. 
Benefit of a tool  
 
 




To dig deeper 
I did not know how to describe my prickly 
sensation in hands and arms. I chose 3 – it was 
very unpleasant when it appeared but it 
disappeared quickly. Whether it was almost 
It can be difficult to grade 
prickly sensations because 
they are very unpleasant 
when they appear but 
The questionnaire does not 
take into account the 
complexity of sensory 
disturbances and the patient 
Risk for 
misunderstanding 
Searching for a 
precise report 
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nothing or a lot I could not tell (P9).  quickly disappear.  must choose the best answer.   
It is important that you read the questions 
properly and not in a hurry. Some I read more 
than once. What did it this question mean? You 
also have to be aware of the division in hands and 
arms and on the next page feet and legs. It could 
be a good idea that the nurses helped us to pay 
attention to this (P2). 
 
Patients may read the 
questionnaire (OANQ) 
properly and pay attention 
to the division in upper and 
lower extremities. May 
need help to recognize this. 
It can be difficult to 
recognize the structure of 
OANQ, which can lead to 
misleading answers. 
Information and guidance 




Searching for a 
precise report 
To dig deeper 
I find it difficult….the patient can experience 
pain in the jaw….but for how long time? 
Answering ‘almost none or quite a lot’ tells 
nothing about how long it has lasted, which 
we also need to know (N5).  
 
The questionnaires tell 
nothing about for how long 
time the CIPN has lasted 
between the treatments. 
The nurses are aware that 
implementing questionnaires 
do not take into account all 
the information they need to 
prevent persistent CIPN.  
Risk for 
misunderstanding 
Searching for a 
precise report  
To dig deeper  
You can describe it with words from another 
patient ‘is it like walking on cotton wool? No, it 
is not like that. Is it like walking on needles? Yes, 
it seems like this’(….) Asking questions and 
explaining symptoms in different ways to reach 
their understandings; suddenly one patient may 
say ‘Oh that is what it means’ (N7). 
To reach the patients 
perspective, nurses use 
words from other patients 
and try to ask questions and 
explain symptoms in 
different ways. 
To improve the patients 
understanding, the nurses 
use everyday language in the 
attempt to identify CIPN. 
Using trial and error, they 












I could have used the questionnaire (when I 
started the treatment) to put into words how I 
feel. What is normal, how much is it okay to be 
The questionnaire can help 
the patient to put side 
effects into words. 
Without inspiration from the 
questionnaires it can be 
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These questions can (….) are coming close to 
you, when you are sitting here alone (….). In 
addition, you suddenly consider ‘can I get these 
side effects as well’ (P2). 
Question in FACT-
GOG/ntx can come close 
and visualise the amount of 
possible side effects. 
FACT-GOG/ntx confronts 
the patient with possible side 
effects and outcomes that 












OANQ is best if you are much focused on facts, 
but you cannot use it if you need to know 
something about my social life. If I lived alone 
without nearby friends and family FACT-
GOG/ntx helps you to express pain and 
loneliness etc. (P6).  
OANQ is focused on facts, 
but tells nothing about 
social life, pain and 
loneliness, which FACT-
GOG/ntx helps you to 
express.  
Neither of the questionnaires 
is sufficient to use alone, 
they have to be combined. 
OANQ versus  
FACT-GOG/ntx 
Recognizing 




I think FACT-GOG/ntx is good because it asks 
questions about nausea and energy, which you 
may also suffer from. On the other hand; OANQ 
asks questions about all the odd thing appearing 
in your hands. They are good, both of them (P3). 
Both questionnaires are 
good but ask questions in 
different areas. 
Using both questionnaires 
supports the opportunity to 
describe CIPN as well as 








Initially, information and action regarding 
neuropathic side effects comes first, everyday life 
comes after. Although OANQ focuses on CIPN, 
we should talk about quality of life as well. 
Overwhelming fatigue may prevent one from 
leaving the house. (….). What does it means to 
them? Regarding FACT-GOG/ntx, if you 
If the patient struggles with 
side effects without a 
support network FACT- 
OG/ntx is appropriate. 
OANQ is more suitable to 
identify patients suffering 
from CIPN. Questions 
To take care of the unique 
patient, choosing one of the 
questionnaires does not 
fulfill the requirements of 
caring in a nursing context. 
Nursing is concerned with 
observations and actions to 
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struggle greatly with side effects without having 
any network, it can be difficult. On the other 
hand, if our goal is to identify patients suffering 
from CIPN, OANQ is more relevant (N1).  
about wellbeing have to do 
with how they influence 
everyday life and not  
grading CIPN. 
help the individual patients’ 
with fundamental care needs 
and everyday living. 
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